The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical research drug factory in Gaithersburg.
Categories:
Related Post
Construction costs rise as tariff clock ticks
Materials prices climbed again in June, according to the latest Producer Price Index, even without…
Major general contractors bullish on data center, AI boom
During the most recent batch of earnings calls, publicly traded firms remained confident on the…
Gateway restarts Hudson Tunnel work as funding uncertainty lingers
The DOT is seeking to reclaim the money it has paid to the Gateway Development…